Objectives & Functions

To provide essential infrastructure in all Public Health Institutions in the State for efficient, qualitative, affordable and effective health services.

The African pharmaceutical market is estimated at €22.1 billion in 2016 (for a global market estimated at over €954.5 billion), with an estimated CAGR of 9.8% between 2010 and 2020. While the African pharmaceutical industry is driven by large multinational producers and public sector producers, it is mostly made up of small private production units that serve their own national markets. More than 70% of the continent's pharmaceutical production is provided by 10 countries: Algeria, Egypt, Côte d'Ivoire, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan and Tunisia. These countries account for more than two-thirds of the continent's GDP. The remaining production is shared by local units. In South Africa and some North African countries, local production has become firmly established. This is the case in Egypt and Tunisia, which produce most of their national drug needs. Morocco, the second largest producer of pharmaceutical products after South Africa, has 40 production plants that meet 70% of domestic demand and exports 10% of this production, mainly to neighboring countries. Significant production capacity is also being developed in Tanzania, Kenya, Uganda, Ethiopia, Ghana, Nigeria and Mozambique.